---
layout: post
title: "Prospective Grant of an Exclusive Patent License: A Diagnostic Tool Based Upon Magnetic Resonance Spectroscopy Pre-Processing and Renormalization"
date: 2026-02-05 18:57:36 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-28397
original_published: 2022-01-03 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of an Exclusive Patent License: A Diagnostic Tool Based Upon Magnetic Resonance Spectroscopy Pre-Processing and Renormalization

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** January 03, 2022 00:00 UTC
**Document Number:** 2021-28397

## Summary

The Food and Drug Administration (FDA) is contemplating the grant of an Exclusive Patent License to practice the invention embodied in the U.S. Patent listed in the SUPPLEMENTARY INFORMATION section of this notice to Voxel Systems, LLC located in Houston, Texas.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/01/03/2021-28397/prospective-grant-of-an-exclusive-patent-license-a-diagnostic-tool-based-upon-magnetic-resonance)
- API: https://www.federalregister.gov/api/v1/documents/2021-28397

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
